Dataset Information

Dysbiosis of Gut Microbiota and Metabolomic Alterations in Myasthenia Gravis: Insights from 16S rRNA Sequencing and Untargeted Metabolomics

ABSTRACT:

Background: Myasthenia gravis (MG) is an autoimmune disorder of neuromuscular transmission. Gut dysbiosis has been implicated in autoimmune pathogenesis, yet integrated microbial and metabolomic profiling in MG remains scarce.

Objectives: To characterize gut microbiota and the fecal metabolome in MG, identify diagnostic biomarkers, and explore associations between microbial taxa, metabolites, and clinical severity.

Methods: Fecal samples from 29 MG patients and 10 healthy controls underwent 16S rRNA sequencing and UHPLC-Q-TOF MS metabolomics. LEfSe identified differential taxa; metabolites were screened by VIP > 1.0, P < 0.05, FDR q < 0.05. Random Forest and Spearman correlation assessed biomarker performance and microbiota–metabolite–clinical associations.

Results: MG patients showed significantly reduced alpha- and beta-diversity. LEfSe identified 232 discriminative taxa, with depletion of butanoic acid-producing commensals (Faecalibacterium prausnitzii, Ruminococcus bromii, Bifidobacterium bifidum) and enrichment of Klebsiella. Metabolomics revealed 567 altered metabolites (424 downregulated), including reduced short-chain fatty acids (SCFAs) and secondary bile acids (lithocholic, isolithocholic, allolithocholic acids). The Random Forest metabolite model achieved AUC = 1.0. Spearman analysis showed lithocholic acid ( P < 0.05) and allocholic acid (P < 0.001) positively correlated with QMG score, and Ruminococcus abundance correlated with butanoic acid (P < 0.01). KEGG analysis implicated cholinergic synapse, bile secretion, sphingolipid signaling, and mTOR pathways.

Conclusions: MG patients exhibit a distinct profile of gut dysbiosis and metabolic disturbances. The specific microbial and metabolic biomarkers identified in this study may offer novel insights for auxiliary diagnosis of MG and guide future microbiota-targeted intervention strategies.

INSTRUMENT(S): Liquid Chromatography MS - positive - hilic, Liquid Chromatography MS - negative - hilic

PROVIDER: MTBLS14266 | MetaboLights | 2026-04-13

REPOSITORIES: MetaboLights

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	a_MTBLS14266_LC-MS_negative_hilic.txt	Txt
	a_MTBLS14266_LC-MS_positive_hilic.txt	Txt
	i_Investigation.txt	Txt
	m_MTBLS14266_LC-MS_negative_hilic_v2_maf.tsv	Tabular
	m_MTBLS14266_LC-MS_positive_hilic_v2_maf.tsv	Tabular

Items per page:

1 - 5 of 6

Similar Datasets

Project description:Objective:To investigate the diversity of nasal microbiota and metabolic characteristics of patients with Type 2 chronic rhinosinusitis, as well as the interactions and potential regulatory relationships between the nasal microbiota and their metabolites by conducting a 16S amplicon sequencing and metabolomics analysis on nasal secretions from patients with Type 2 chronic rhinosinusitis.Methods:28 patients with Type 2 Chronic Rhinosinusitis (T2-CRS) were selected from the Guangzhou Red Cross Hospital Affiliated to Jinan University. These patients underwent endoscopic sinus surgery and were diagnosed with T2-CRS between July 2023 and October 2024, based on the presence of eosinophilic infiltration (Eos10/high-power field) in the nasal polyp pathological tissues after surgery. 12 healthy individuals without nasal disease was enrolled as the control group. For each participant, two samples of nasal secretions were collected. One sample was processed using 16S amplicon sequencing technology on the Agilent 2100 Bioanalyzer platform, targeting the V3-V4 hypervariable regions of the 16S rDNA to sequence all bacterial taxa present in the sample. The sequencing results were subjected to Operational Taxonomic Unit (OTU) clustering, followed by bioinformatics analyses (including α-diversity and β-diversity analyses, LEfSe analysis, and differential abundance analysis) and statistical processing to characterize and compare the nasal microbiota profiles and differences between the T2-CRS group and the control group. The other tube of nasal secretion sample was subjected to extraction and analyzed using Ultra-Performance Liquid Chromatography coupled with Mass Spectrometry (UPLC-MS). The mass spectrometry data were interpreted by integrating information from the BGI Metabolome database, the mzCloud database, and the ChemSpider online database. This approach facilitated the identification and comparison of the metabolic profiles and differences in nasal microbiota metabolites between the T2-CRS group and the control group. Finally, the identified differentially abundant microbiota and metabolites were analyzed through an integrative multi-omics approach. This reveals the metabolites closely related to the distribution of microbial communities and the dominant species that induce metabolic changes, and explores the intrinsic regulatory pathways of the organism involving nasal microbiota and metabolites.Results:The sequencing results showed that both T2-CRS patients and healthy control group had a rich and diverse bacterial community in the nasal cavity. Compared with the healthy control group, the T2-CRS group exhibited a decrease in α-diversity, with statistically significant differences (P < 0.05) observed in the α-diversity-related indices, including the Chao 1 index, Sobs index, Coverage index, and Shannon index. Principal Coordinates Analysis (PCoA) revealed a significant difference in β-diversity between the two groups (P < 0.05). At the phylum level, the nasal microbiota of the T2-CRS group had higher relative abundances of Fusobacteriota, Acidobacteriota, and Campylobacterota, with significant differences (P < 0.05). In contrast, the nasal microbiota of the control group had higher relative abundances of Pseudomonadota, Actinomycetota, Bacteroidota, and Gemmatimonadota, but these differences were not statistically significant (P > 0.05). At the genus level, the nasal microbiota of the T2-CRS group exhibitedhigher relative abundances of Haemophilus, Pseudomonas, and Burkholderia, with significant differences (P < 0.05). In the control group, the relative abundances of Sphingomonas, Bradyrhizobium, Cutibacterium, Methylorubrum, and Lawsonella were higher and showed significant differences (P < 0.05). At the species level, Haemophilus species, Pseudomonas aeruginosa, and Burkholderia cepacia exhibited higher relative abundances in the T2-CRS group with significant differences (P < 0.05). In contrast, the control group had higher relative abundances of Sphingomonas azotifigens, Cutibacterium acnes, Methylorubrum extorquens, and Lawsonella clevelandensis, with significant differences observed (P < 0.05).In terms of metabolomics, there were significant differences in the metabolic profiles between the T2-CRS group and the control group. A total of 46 differential metabolites were identified using fold change (FC), P-value, and variable importance in projection (VIP) values. In the T2-CRS group, the upregulated metabolites mainly included 10Z - nonadecenoic acid, 4 -hydroxyphenylpyruvic acid, pimelic acid, indoleacetic acid, and others, predominantly fatty acids.In the T2-CRS group, the downregulated metabolites mainly included Leucine, L-aspartic acid, Asparagine, D-ornithine, L-glutathione oxidized etc., predominantly amino acids. These differential metabolites were primarily annotated and enriched in metabolic pathways liketryptophan metabolism, glycerophospholipid metabolism, glutathione metabolism, and arginine and proline metabolism. Subsequently, 10 potential biomarkers were selected based on their biological significance and the receiver operating characteristic (ROC) curve analysis, including 10Z - nonadecenoic acid, 4 - hydroxyphenylpyruvic acid, indoleacetic acid etc.After conducting an integrative multi omics analysis of the differential microbial communities and metabolites, it was revealed that certain differential microbes, such as Haemophilus species, Staphylococcus aureus, and Streptococcus pneumoniae, were significantly positively correlated with specific metabolites, including 10Z - nonadecenoic acid, 4 - hydroxyphenylpyruvic acid, L -kynurenine, and xanthine (P < 0.05). Differential microbes such as Lawsonella clevelandensis, Pseudomonas aeruginosa, and Sphingomonas azotifigens exhibited significant negative correlations with metabolites including L(+) - ornithine, guanidoacetic acid, and leucine (P < 0.05).Conclusions:This study elucidated the potential pathogenesis of T2-CRS from the perspectives of microbiomics, metabolomics, and their integrative analysis, with the aim of providing new directions for the diagnosis and targeted treatment of T2-CRS.

Project description: Background: Lactoferrin is a natural iron-binding glycoprotein with antimicrobial, immunomodulatory and barrier-protective activities, and it is widely applied in human nutritional supplements and infant food additives, but its application potential in pet food remains undetermined. This study investigated the influence of dietary lactoferrin on immune functions, intestinal barrier integrity and gut microbiota in kittens. Results: A total of 24 healthy kittens aged 5-10 months were divided into three groups (n = 8) and fed with a commercial basal diet (CON group) and the basal diet supplemented with 500 or 1000 mg/kg lactoferrin (L-LF group or H-LF group), respectively, for 42 days. Blood was collected from individual kittens on days 21 and 42, and feces of each animal were collected on day 42. Compared with the CON group, the L-LF and H-LF groups increased immunoglobulin A levels on day 21 (P < 0.05). The H-LF group showed lower serum IL-6 level on day 21, and both L-LF and H-LF groups reduced IL-1β concentration on day 42 (P < 0.05), in contrast with the CON group. Additionally, serum levels of lipopolysaccharide and zonulin were decreased in the H-LF group relative to the CON group on day 42 (P < 0.05). Untargeted metabolomics analysis revealed that dietary lactoferrin altered serum metabolite profiles and increased levels of sphingosine 1-phosphate, proline betaine, L-argininium(1+), and carnitine. The L-LF and H-LF groups were enriched in 5 and 6 differential metabolic pathways, respectively. Metagenomic analysis of fecal samples indicated that both the L-LF and H-LF groups had a higher relative abundance of Bacteroidota than the CON group (P < 0.05). The H-LF group also increased the relative abundance of Prevotellaceae, Prevotella, Bifidobacterium and Segatella copri in the feces of kittens (P < 0.05). Moreover, the abundance of Escherichia coli in both L-LF and H-LF groups declined compared with the CON group (P < 0.05). Furthermore, KEGG pathways of secondary metabolite biosynthesis, nucleotide sugar biosynthesis, and sphingolipid metabolism were significantly enriched in kittens fed with lactoferrin.Conclusions: Dietary lactoferrin improved the immune function, strengthened intestinal barrier integrity and remodeled gut microbiota in kittens, highlighting its potential as a functional additive in kitten food.

Project description:succinate (SUC), as a feed additive, can regulate muscle fiber structure and fat deposition, and has a positive effect on meat quality. In this study, 30 male Tan sheep lambs were selected to investigate the effects of SUC in diet on Tan sheep production performance, lamb quality, muscle fiber structure, liver and longissimus' muscle entities (LT) transcriptomes. Different levels of SUC were fed (0%, 1.0%, 2.0%, respectively) and the experiment lasted for 60 days. Compared with CON group, 2% SUC group significantly increased average daily gain from 1 to 15 days and 46 to 60 days during the experiment period, and significantly increased dry matter intake from 1 to 15 days, 16 to 30 days and 46 to 60 days during the experiment period (P<0.05). Both 1% SUC group and 2% SUC group could decrease feed to gain ratio and increase carcass weight (P<0.05). The slaughter rate of 2% SUC group was significantly increased (P=0.012). In both 1% SUC and 2% SUC groups, shear force and cooking loss were decreased, intramuscular fat was increased, and a* of LT muscle was increased (P=0.036). In addition, the muscle fiber structure of Tan sheep LT muscle in 1% SUC group and 2% SUC group was changed, the diameter of muscle fiber was decreased, the cross-sectional area of type Ⅰ and type Ⅱa muscle fiber was decreased, and the density of type Ⅰ muscle fiber was increased (P<0.05). Transcriptomic results showed that the addition of SUC can change the expression of muscle development and muscle fiber type transformation genes. Differential genes are mainly involved in various pathways related to lipid metabolism, energy metabolism and muscle development, improve muscle glucose uptake capacity, and improve meat quality in circadian rhythm. In conclusion, SUC can regulate the nutritional metabolism of Tan Sheep, change the muscle fiber structure of Tan Sheep, and improve the production performance and meat quality. Our results show that adding 1% SUC to the Tan sheep diet is productively more beneficial.

Dataset Information

Dysbiosis of Gut Microbiota and Metabolomic Alterations in Myasthenia Gravis: Insights from 16S rRNA Sequencing and Untargeted Metabolomics

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets